FDANews

GLAXO TO CHALLENGE HERCEPTIN AT TOP CANCER MEETING

GlaxoSmithKline Plc hopes to grab the headlines at the world's top cancer meeting early next month with a barrage of data, including key trial results for a new breast cancer pill challenging blockbuster Herceptin.

The Scotsman (http://business.scotsman.com/latest.cfm?id=771632006)